Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7327 p785
27 November 2004

This article
Reprint   Photocopy

PDF 90K, Acrobat Reader

Letters

· Registration exam (2)
· Pharmacist prescribing
· Agenda for change
· New contract (3)
· Retention fees (2)
· Statins
· Levothyroxine
· The Journal


Letters to the Editor

The Journal

Results are meaningless

From Mr R. Sinclair, MRPharmS

Am I alone in questioning the statistical significance of an increase in the eradication of abdominal infection of 0.4 per cent, as indicated in a brief item in The Journal (13 November, p709)?
The report quotes the results of a single unidentified study that showed a 91.3 per cent eradication rate for tigecycline against 89.9 per cent for imipenem with cilastatin. I am in no position to question the claims for the actual study but, at a time when the publication of research results are in the public eye, to quote such a figure with no other supporting data, such as a sample size, confidence interval, etc, in my view, renders the results meaningless.

Roy Sinclair
New Malden, Surrey

 

The news report did not suggest any statistical significance, and hence superiority of one drug over the other. Instead, it aimed to illustrate that tigecycline shows promise as an antibacterial agent with similar efficacy to another treatment option.
EDITOR

Send your letter to The Editor

Previous Topic (Levothyroxine)

Back to Top


©The Pharmaceutical Journal